95
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Molecular mechanisms and clinical applications of angiogenesis.

      Nature

      Angiogenesis Inhibitors, pharmacology, therapeutic use, Animals, Blood Vessels, growth & development, pathology, physiology, physiopathology, Fibroblast Growth Factors, metabolism, Humans, Neovascularization, Physiologic, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, antagonists & inhibitors, Vesicular Transport Proteins

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.

          Related collections

          Author and article information

          Journal
          21593862
          4049445
          10.1038/nature10144

          Comments

          Comment on this article